Skip to content

Clinical Study on the Curative Effect of Acupoints of Stomach Channel on Weight Loss and Hypoglycemic Action in Type 2 Diabetic Patients with Obesity

Clinical Study on the Curative Effect of Acupoints of Stomach Channel on Weight Loss and Hypoglycemic Action in Type 2 Diabetic Patients with Obesity

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400084243
Enrollment
Unknown
Registered
2024-05-13
Start date
2020-11-01
Completion date
Unknown
Last updated
2024-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

acupuncture group:acupuncture
Control group:sham acupuncture

Sponsors

Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)Patients aged 18 to 70 years old,gender:unlimited (2)BMI>28, BMI=weight(kg)÷height^2(m) (3)Patients symptoms meet the criteria of diabetes:FBG(fasting blood-glucose) greater than or equal to 7.0mmol/L,and/or 2hPG(2-hour postprandial blood glucose)greater than or equal to 11.1mmol/L. (4)Patients willing to participate in the research and to sign an informed consent.

Exclusion criteria

Exclusion criteria: (1)Patients have severe organic diseases,such as advanced tumor,cardiac, hepatic, renal or mental diseases,and Patients who taked long-term courses of hormone drugs (2)The females who are pregnant or breast-feeding; (3)Patients who is unfit to receive treatment of acupuncture; (4)Patients who refused to participate in the research.

Design outcomes

Primary

MeasureTime frame
changes in weight;

Secondary

MeasureTime frame
Other body shape indicators: neck circumference, chest circumference, waist circumference, hip circumference, blood pressure;Blood glucose indicators: fasting and 2h blood sugar after meals, glycosylated hemoglobin, glucose tolerance (OGTT); Blood lipid indicators: total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol;Appetite scale score;Magnetic resonance to determine changes in brain function;Changes in liver fat content determined by magnetic resonance PDFF method;Changes in body fat distribution;

Countries

China

Contacts

Public ContactXiangyu Wang

Zhongshan Hospital, Fudan University, Shanghai, 200032, China.

wangxyzsh@126.com+86 136 6184 6210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026